1887

Abstract

Varicella-zoster virus (VZV) glycoproteins were purified from infected cells using monoclonal antibodies and gH:gL was found to react with antibodies to the γ chain of human IgG (h-IgG), whereas gE:gI and gB did not. When gH:gL was captured by concanavalin A, it lost reactivity with the anti-h-IgG γ chain (anti-h-γ-IgG). gH:gL reacted with anti-h-γ-IgG in an ELISA assay and gave a value of 2·16×10 M in a BIAcore assay. The value of the human monoclonal antibody to gH (TI-57) used for the purification of gH:gL was 4·45×10 M. Virus pretreated with anti-h-IgG was five times more resistant to neutralization with TI-57. Although the nature of the binding was not clear, gH:gL bound to anti-h-γ-IgG. If this interaction results from immunological similarity between gH:gL and h-IgG, it may cause immune evasion in the pathogenesis of VZV infection.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-82-2-331
2001-02-01
2019-12-09
Loading full text...

Full text loading...

/deliver/fulltext/jgv/82/2/0820331a.html?itemId=/content/journal/jgv/10.1099/0022-1317-82-2-331&mimeType=html&fmt=ahah

References

  1. Duus, K. M., Hatfield, C. & Grose, C. ( 1995; ). Cell surface expression and fusion by the varicella-zoster virus gH:gL glycoprotein complex: analysis by laser scanning confocal microscopy. Virology 210, 429-440.[CrossRef]
    [Google Scholar]
  2. Forghani, B., Ni, L. & Grose, C. ( 1994; ). Neutralization epitope of the varicella-zoster virus gH:gL glycoprotein. Virology 199, 458-462.[CrossRef]
    [Google Scholar]
  3. Forrester, A., Farrell, H., Wilkinson, G., Kaye, J., Davis-Poynter, N. & Minson, T. ( 1992; ). Construction and properties of a mutant of herpes simplex virus type 1 with glycoprotein H coding sequences deleted. Journal of Virology 66, 341-348.
    [Google Scholar]
  4. Fuller, A. O., Santos, R. E. & Spear, P. G. ( 1989; ). Neutralizing antibodies specific for glycoprotein H of herpes simplex virus permit viral attachment to cells but prevent penetration. Journal of Virology 63, 3435-3443.
    [Google Scholar]
  5. Grose, C. ( 1990; ). Glycoproteins encoded by varicella-zoster virus: biosynthesis, phosphorylation, and intracellular trafficking. Annual Review of Microbiology 44, 59-80.[CrossRef]
    [Google Scholar]
  6. Kamiyama, T., Sato, H., Takahara, T., Kageyama, S. & Shiraki, K. ( 2000; ). Novel immunogenicity of Oka varicella vaccine vector expressing hepatitis B surface antigen. Journal of Infectious Diseases 181, 1158-1161.[CrossRef]
    [Google Scholar]
  7. Matsui, S., Okuno, T. & Shiraki, K. ( 1994; ). Functional roles of terminal glycomoieties in varicella-zoster virus infection. Virology 198, 50-58.[CrossRef]
    [Google Scholar]
  8. Montalvo, E. & Grose, C. ( 1986; ). Neutralization of epitope of varicella-zoster virus on native viral glycoproteins gp118 (VZV glycoprotein gpIII). Virology 149, 230-241.[CrossRef]
    [Google Scholar]
  9. Okuno, T., Yamanishi, K., Shiraki, K. & Takahashi, M. ( 1983; ). Synthesis and processing of glycoproteins of varicella-zoster virus (VZV) as studied with monoclonal antibodies to VZV antigens. Virology 129, 357-368.[CrossRef]
    [Google Scholar]
  10. Sato, H., Kageyama, S., Imakita, M., Ida, M., Yamamura, J., Kurokawa, M. & Shiraki, K. ( 1998; ). Immune response to varicella-zoster virus glycoproteins in guinea pigs infected with Oka varicella vaccine. Vaccine 16, 1263-1269.[CrossRef]
    [Google Scholar]
  11. Shiraki, K. & Takahashi, M. ( 1982; ). Virus particles and glycoproteins excreted from cultured cells infected with varicella-zoster virus (VZV). Journal of General Virology 61, 271-275.[CrossRef]
    [Google Scholar]
  12. Shiraki, K., Okuno, T., Yamanishi, K. & Takahashi, M. ( 1982; ). Polypeptides of varicella-zoster virus (VZV) and immunological relationship of VZV and herpes simplex virus (HSV). Journal of General Virology 61, 255-269.[CrossRef]
    [Google Scholar]
  13. Shiraki, K., Sato, H., Yamamura, J., Li, Z. H., Yokoyama, T., Hasegawa, T., Okuno, T., Kurokawa, M. & Kageyama, S. ( 1997; ). Functions of purified gB, gE:gl, and gH:gL, and their sialyl residues in varicella-zoster virus infection. Archives of Virology 142, 2295-2301.[CrossRef]
    [Google Scholar]
  14. Sugano, T., Matsumoto, Y., Miyamoto, C. & Masuho, Y. ( 1987; ). Hybridomas producing human monoclonal antibodies against varicella-zoster virus. European Journal of Immunology 17, 359-364.[CrossRef]
    [Google Scholar]
  15. Sugano, T., Tomiyama, T., Matsumoto, Y., Sasaki, S., Kimura, T., Forghani, B. & Masuho, Y. ( 1991; ). A human monoclonal antibody against varicella-zoster virus glycoprotein III. Journal of General Virology 72, 2065-2073.[CrossRef]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-82-2-331
Loading
/content/journal/jgv/10.1099/0022-1317-82-2-331
Loading

Data & Media loading...

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error